Meridian Bioscience (VIVO) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.90 +0.62%
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Meridian Bioscience (Nasdaq: VIVO) reported Q4 EPS of $0.19, in-line with the analyst estimate of $0.19. Revenue for the quarter came in at $48 million versus the consensus estimate of $46.2 million.
Meridian Bioscience reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
